I am interested in understanding the interplay of factors that contribute to healthy or pathological brain aging. In particular, the effect of factors that contribute to or protect against the development of Alzheimer's disease.
Ozioma is an Assistant Professor and Clinical Neuropsychologist. He is interested in elucidating how early brain changes interface with genetics and other molecular alterations to influence progression from cognitive normalcy to symptomatic Alzheimer's disease.
Vikas is an Assistant Professor in the Biostatistics & Medical Informatics and Computer Sciences at UW. He specializes in image analysis, computer vision and machine learning.
I am interested in identifying imaging biomarkers that can be used to reliably predict development of Alzheimer's disease. Currently, I am investigating the relationship of white matter hyperintensities with cerebral perfusion and cognition in adult children of persons with AD.
Catherine Gallagher , MD, is a neurologist and movement disorders specialist who is studying PET and MRI biomarkers in Parkinson’s disease. She is also experienced in the diagnosis of AD and non-Alzheimer dementias.
Dr. Howard A. Rowley is co-director of the Wisconsin ADRC imaging service. He is a Professor of Radiology, Neurology, and Neurosurgery; Chief of Neuroradiology; and the Joseph F. Sackett Professor of Radiology at the University of Wisconsin, Madison.
I'm interested in the neurobiological and psychological processes that affect memory; early detection of Alzheimer's Disease; imaging markers of AD progression; brain changes in normal aging; the effect of intervention on the brain in aging and AD.
Dr. Asthana is Professor of Medicine; Section head of Geriatrics, VA GRECC Director, and ADRC Director. He specializes in dementia characterization and evaluation of interventions for AD.
Dr. Gleason is a clinical neuropsychologist and the Administrative Director of the Wisconsin Alzheimer's Disease Research Center. She conducts studies on the effect of hormones on cognition and brain function and also conducts studies on cognitive and brain factors that make elderly individuals at greater risk for falls.
I am interested in developing and applying advanced MRI imaging techniques to characterize early changes in Alzheimer's Disease brain. Major research focus on using multimodal imaging approach including cerebral blood flow, brain metabolism and amyloid images to understand the pathophysiological changes associated with AD risks.
The research of my group is focused on developing imaging and analysis techniques for the study of human brain function with magnetic resonance imaging (MRI) at 3 tesla. My research group is actively involved in functional MRI techniques, functional MRI of TMS brain stimulation, white matter organization mapping, and structural characterization of brain tissues.
Dr. Carlsson’s research focuses on the effects of vascular risk factors and their treatments on cognition and biomarkers for Alzheimer’s disease in persons at risk for dementia.
My research involves the development and application of PET methodologies to investigate neurochemical changes in the brain, including studying novel radioligands to characterize neurotransmitter-protein interactions and how they are influenced by the effects of neuropsychiatric disease and psychotropic drugs.
Dr. Puglielli's broad research interests focus on the role that lipid metabolism plays in the regulation of Aβ (amyloid β-peptide) generation and synaptogenesis during both normal aging of the brain and the Alzheimer-type of neurodegeneration. Specifically, we focus on the role played by the ceramide-dependent signaling cascade, and by intracellular cholesterol distribution.
Dr. Sager is Director of the Wisconsin Alzheimer's Institute and a Professor of Medicine at the University of Wisconsin-Madison School of Medicine and Public Health. He is the founder of the Wisconsin Registry for Alzheimer's Prevention (WRAP) which is a longitudinal study of adult children of persons with Alzheimer's disease.
Dr Dowling is a statistician in the Wisconsin ADRC
Amy is the Imaging Program Manager for the Wisconsin Alzheimer's Disease Research Center (W-ADRC); she will get you in contact with the correct people and work with you so that the imaging portion of your research goes smoothly.
My research interests are at the intersection of Machine Learning, Medical Imaging, and Neuroscience, where I hope to use each problem domain to drive advances in the others.
My main research interests lie in further understanding age-related structural changes and socioemotional processing in the aging brain. In addition to functional and structural magnetic resonance imaging, she hopes to apply methods for multimodal imaging and network connectivity analysis.